Field trials on a live bovine respiratory syncytial virus vaccine in calves.
Field trials were carried out in calves using a live bovine respiratory syncytial (BRS) virus vaccine prepared from the attenuated BRS virus, strain rs-52. Two hundred seventy-five and 353 calves were vaccinated intranasally and intramuscularly, respectively. No undesirable postvaccinal reactions were observed in the vaccinated calves. Of the serum neutralizing (SN) antibody negative calves 89.7% (26/29) and 92.8% (90/97) developed SN antibody 1 month after intranasal and intramuscular vaccination, respectively. Most of the calves having SN antibody titers of 1:1 or 1:2 at the time of vaccination showed a significant increase in SN antibody titer. About 70% and 90% of the calves vaccinated intranasally and intramuscularly, respectively, maintained SN antibody for 6 months after vaccination. In a field trial, a natural BRS virus infection occurred about 5 months after the start of the trial. Ten of the 16 unvaccinated control calves showed respiratory symptoms due to BRS virus infection. On the contrary, all of the 68 vaccinated calves exhibited no symptoms at all, indicating efficacy of the vaccine.
Kubota
M
M
Division of Veterinary Microbiology, Kyoto Biken Laboratories, Inc., Japan.
Fukuyama
S
S
Takamura
K
K
Izumida
A
A
Kodama
K
K
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D002417:Cattle / Q000276:immunology*; D002418:Cattle Diseases / Q000517:prevention & control; D009500:Neutralization Tests / Q000662:veterinary; D012136:Respiratory Syncytial Viruses / Q000276:immunology*; D012141:Respiratory Tract Infections / Q000517:prevention & control / Q000662:veterinary; D010253:Respirovirus Infections / Q000517:prevention & control / Q000662:veterinary; D014613:Vaccines, Attenuated / Q000009:adverse effects / Q000276:immunology; D014765:Viral Vaccines / Q000009:adverse effects / Q000276:immunology*
D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines